­
medigraphic.com
ISSN 2007-6800 (Print)

2020, Number S2

<< Back Next >>

Rev Mex Traspl 2020; 9 (S2)

History of coronavirus infections and epidemiology of SARS-CoV-2 infection

Velázquez-Silva RI

Language: Spanish
References: 107
Page: 149-159
PDF size: 327.52 Kb.


ABSTRACT

The first description of the human coronavirus (CoV) was in 1965 by Tyrrell and was so named because of crown-like projections from its surface. CoV’s usually cause respiratory and gastrointestinal diseases in humans. The first epidemics were caused by SARS-CoV (Severe Acute Respiratory Syndrome CoV) in 2002 and by MERS-CoV (Middle East Respiratory Syndrome CoV) in 2012. The current epidemic is caused by the new coronavirus called SARS-CoV-2 causing of COVID-19 disease. The first cases were reported in Wuhan, China, in December 2019 and since then the spread of the disease has been global. The World Health Organization declared it a pandemic on March 11, 2020. By May 27, a total of 5,488,825 confirmed cases of SARS-CoV-2 have been reported worldwide, the most affected continent is the American with 2,495,924 cases, followed by Europe with 2,061,828 cases. In Mexico, the first case was diagnosed on February 28, 2020. Initially in China it was reported that 14% of patients presented with moderate symptoms, 4.7% critically ill patients, and 2.3% mortality with variability in different countries. In Mexico mortality is higher (9.2%). The presentation of the disease in patients with chronic kidney disease is atypical (diarrhea in one third of patients) and with higher mortality (16.2-52%). In kidney transplant recipients, COVID-19 disease presents with greater complications and higher mortality (10-66%).


REFERENCES

  1. Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J. 2005; 24 (11 Suppl): S223-S226.

  2. Tyrrell DAJ, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966; 287 (7428): 76-77.

  3. Almeida JD, Tyrrell DAJ. The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol. 1967; 1 (2): 175-178.

  4. Tyrrell DAJ, Almeida JD, Cunningham CH, Dowdle WR, Hofstad MS, McIntosh K et al. Coronaviridae. Intervirology. 1975; 5 (1-2): 76-82.

  5. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17 (3): 181-192.

  6. Hui DSC, Zumla A. Severe acute respiratory syndrome. Infect Dis Clin N Am. 2019; 33 (4): 869-889.

  7. Zhong N, Zheng B, Li Y, Poon L, Xie Z, Chan K et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet. 2003; 362 (9393): 1353-1358.

  8. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348 (20): 1967-1976.

  9. Fouchier RAM, Kuiken T, Schutten M, van Amerongen G, van Doornum GJJ, van den Hoogen BG et al. Koch’s postulates fulfilled for SARS virus. Nature. 2003; 423 (6937): 240-240.

  10. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348 (20): 1953-1966.

  11. Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003; 52 (Pt 8): 715-720.

  12. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (London, England). 2003; 361 (9366): 1319-1325.

  13. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348 (20): 1977-1985.

  14. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003; 361 (9371): 1773-1778.

  15. Wong RSM, Hui DS. Index patient and SARS outbreak in Hong Kong. Emerg Infect Dis. 2004; 10 (2): 339-341.

  16. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348 (20): 1986-1994.

  17. WHO. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 [Internet]. 2003 [cited 2020 Apr 18]. Available in: https://www.who.int/csr/sars/country/table2004_04_21/en/

  18. WHO. Update 95-SARS: Chronology of a serial killer [Internet]. Available in: https://www.who.int/csr/don/2003_07_04/en/

  19. Hui DSC, Sung JJY. Severe acute respiratory syndrome. Chest. 2003; 124 (1): 12-15.

  20. Peiris JSM, Yuen KY, Osterhaus ADME, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003; 349 (25): 2431-2441.

  21. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci. 2005; 102 (7): 2430-2435.

  22. Wang M, Yan M, Xu H, Liang W, Kan B, Zheng B et al. SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis. 2005; 11 (12): 1860-1865.

  23. Lau SKP, Li KSM, Tsang AKL, Lam CSF, Ahmed S, Chen H et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol. 2013; 87 (15): 8638-8650.

  24. Hu B, Zeng LP, Yang XL, Ge XY, Zhang W, Li B et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017; 13 (11): e1006698.

  25. Yang XL, Hu B, Wang B, Wang MN, Zhang Q, Zhang W et al. Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus. J Virol. 2016; 90 (6): 3253-3256.

  26. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013; 503 (7477): 535-538.

  27. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013; 19 (10): 1697-1699.

  28. Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol. 2005; 79 (18): 11892-11900.

  29. Lau SKP, Woo PCY, Li KSM, Huang Y, Tsoi HW, Wong BHL et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci. 2005; 102 (39): 14040-14045.

  30. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (New York, NY). 2003; 302 (5643): 276-278.

  31. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24 (6): 490-502.

  32. Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017; 25 (1): 35-48.

  33. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH et al. Bats are natural reservoirs of SARS-like coronaviruses. Science (New York, NY). 2005; 310 (5748): 676-679.

  34. Hon CC, Lam TY, Shi ZL, Drummond AJ, Yip CW, Zeng F et al. Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. J Virol. 2008; 82 (4): 1819-1826.

  35. Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang YP et al. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol. 2004; 4 (1): 21.

  36. Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997; 48: 1-100.

  37. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014; 370 (26): 2499-2505.

  38. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) [Internet]. [cited 2020 Apr 19]. Available in: https://www.who.int/emergencies/mers-cov/en/

  39. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367 (19): 1814-1820.

  40. Memish ZA, Perlman S, van Kerkhove MD, Zumla A. Middle East respiratory syndrome. Lancet (London, England). 2020; 395 (10229): 1063-1077.

  41. Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013; 19 Suppl 1: S12-S18.

  42. Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR et al. Hospital-associated outbreak of middle east respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014; 59 (9): 1225-1233.

  43. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L et al. Middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol. 2013; 87 (14): 7790-7792.

  44. Assiri A, McGeer A, Perl TM, Price CS, al Rabeeah AA, Cummings DAT et al. Hospital outbreak of middle east respiratory syndrome coronavirus. N Engl J Med. 2013; 369 (5): 407-416.

  45. Oh M, Park WB, Park SW, Choe PG, Bang JH, Song KH et al. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018; 33 (2): 233-246.

  46. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle east respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017; 95 (2): 207-213.

  47. Alanazi KH, Killerby ME, Biggs HM, Abedi GR, Jokhdar H, Alsharef AA et al. Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017. Infect Control Hosp Epidemiol. 2019; 40 (1): 79-88.

  48. Chu DKW, Hui KPY, Perera RAPM, Miguel E, Niemeyer D, Zhao J et al. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A. 2018; 115 (12): 3144-3149.

  49. Raj VS, Farag EABA, Reusken CBEM, Lamers MM, Pas SD, Voermans J et al. Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis. 2014; 20 (8): 1339-1342.

  50. Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A et al. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis. 2014; 20 (12): 2093-2095.

  51. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet (London, England). 2015; 386 (9997): 995-1007.

  52. Gong L, Li J, Zhou Q, Xu Z, Chen L, Zhang Y et al. A New Bat-HKU2-like Coronavirus in Swine, China, 2017. Emerg Infect Dis. 2017; 23 (9): 1607-1609.

  53. Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature. 2018; 556 (7700): 255-258.

  54. Lau SKP, Woo PCY, Li KSM, Huang Y, Wang M, Lam CSF et al. Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology. 2007; 367 (2): 428-439.

  55. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506.

  56. Green A. Li Wenliang. Lancet [Internet]. 2020; 395 (10225): 682. Available in: https://doi.org/10.1016/S0140-6736 (20)30382-2

  57. WHO. This statement is updated on an ongoing basis, in response to evolving events and common media queries. [Internet]. 2020 [cited 2020 May 18]. Available in: www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19

  58. Secretaría de Salud. Información Internacional y Nacional sobre nuevo Coronavirus (COVID-2019) [Internet]. 2020 [citado 18 de mayo de 2020]. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/538453/Comunicado_Tecnico_Diario_COVID-19_2020.02.28.pdf

  59. World Health Organization. Novel coronavirus situation report-2 [Internet]. 2020 [cited 2020 Apr 1]. Available in: www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov.pdf

  60. Stadnytskyi V, Bax CE, Bax A, Anfinrud P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci U S A. 2020; 117 (22): 11875-11877.

  61. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020; 323 (16): 1610-1612.

  62. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; NEJMc2004973.

  63. Prevention C for DC and Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection, Updated February 12, 2020 [Internet]. 2020 [cited 2020 Apr 1]. Available in: www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

  64. Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020; 9 (1): 469-473.

  65. Tang A, Tong ZD, Wang HL, Dai YX, Li KF, Liu JN et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020; 26 (6): 1337-1339.

  66. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020; 323 (18): 1843-1844.

  67. WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-2019). 2020.

  68.  68. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382 (13): 1199-1207.

  69. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England). 2020; 395 (10223): 514-523.

  70. WHO. Coronavirus disease (COVID-19) situation report - 128 data as received by WHO from national authorities by 10: 00 CEST, 27 May 2020 [Internet]. 2020 [cited 2020 May 27]. Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200527-covid-19-sitrep-128.pdf?sfvrsn=11720c0a_2

  71. WHO. Coronavirus disease (COVID-19) outbreak situation, Last update: 27 May 2020, 19: 00 GMT-5 [Internet]. 2020 [cited 2020 May 4]. Available in: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

  72. Team TNCPERE. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly [Internet]. 2 (8): 113-22. Available in: http: //weekly.chinacdc.cn//article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51

  73. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; NEJMoa2002032.

  74. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; e200994.

  75. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382 (10): 929-936.

  76. Bhatraju PK, Ghassemieh BJ, Nichols M et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020; 382 (21): 2012-2022.

  77. Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020; 323 (20): 2052-2059.

  78. Secretaría de Salud. Información Internacional y Nacional sobre nuevo Coronavirus (COVID-2019) [Internet]. 2020 [citado 27 de mayo de 2020]. Disponible en: https://coronavirus.gob.mx/datos/

  79. Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A et al. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. medRxiv [Internet]. 2020; 2020.04.20.20072223. Available in: http://medrxiv.org/content/early/2020/05/05/2020.04.20.20072223.abstract

  80. Mejia-Vilet JM, Cordova-Sanchez BM, Fernandez-Camargo D, Mendez-Perez RA, Morales-Buenrostro LE, Hernandez-Gilsoul T. Derivation of a score to predict admission to intensive care unit in patients with COVID-19: the ABC-goals score. medRxiv [Internet]. 2020; 2020.05.12.20099416. Available in: http: //medrxiv.org/content/early/2020/05/16/2020.05.12.20099416.abstract

  81. Wang R, Liao C, He H et al. COVID-19 in hemodialysis patients: a report of 5 cases. Am J Kidney Dis. 2020. doi: 10.1053/j.ajkd.2020.03.009.

  82. Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv [Internet]. 2020; 2020.02.24.20027201. Available in: http://medrxiv.org/content/early/2020/02/27/2020.02.24.20027201.abstract

  83. Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020. doi: 10.1681/ASN.2020030354.

  84. Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020; CJN.04160320. doi: 10.2215/CJN.04160320.

  85. Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, González Rojas Á, Bascuñana A et al. COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Kidney Int. 2020; S0085-2538(20)30509-3. doi: 10.1016/j.kint.2020.04.031.

  86. Scarpioni R, Manini A, Valsania T, de Amicis S, Albertazzi V, Melfa L et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale “Guglielmo da Saliceto” in Piacenza. G Ital Nefrol. 2020; 37 (2).

  87. La Milia V, Bacchini G, Bigi MC, Casartelli D, Cavalli A, Corti M et al. COVID-19 outbreak in a large hemodialysis centre in Lombardy, Italy. Kidney Int Rep [Internet]. 2020. Available in: https://doi.org/10.1016/j.ekir.2020.05.019

  88. Michaels MG, la Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, Green M et al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant. 2020. doi: 10.1111/ajt.15832.

  89. Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003; 3 (8): 977-981.

  90. AlGhamdi M, Mushtaq F, Awn N, Shalhoub S. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant. 2015; 15 (4): 1101-1104.

  91. Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020; ajt.15869.

  92. Zhang H, Chen Y, Yuan Q, Xia QX, Zeng XP, Peng JT et al. Identification of kidney transplant recipients with coronavirus disease 2019. Eur Urol. 2020; 77 (6): 742-747.

  93. Zhu L, Gong N, Liu B, Lu X, Chen D, Chen S et al. Coronavirus Disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China. Eur Urol. 2020; 77 (6): 748-754.

  94. Kim Y, Kwon O, Paek JH et al. Two distinct cases with COVID-19 in kidney transplant recipients. Am J Transplant. 2020. doi: 10.1111/ajt.15947.

  95. Gandolfini I, Delsante M, Fiaccadori E, Zaza G, Manenti L, Degli Antoni A et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020.

  96. Guillen E, Pineiro GJ, Revuelta I, Rodriguez D, Bodro M, Moreno A et al. Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? Am J Transplant. 2020.

  97. Fernández-Ruiz M, Andrés A, Loinaz C, Delgado JF, López-Medrano F, San Juan R et al. COVID-19 in solid organ transplant recipients: A single-center case series from Spain. Am J Transplant. 2020.

  98. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020; 97 (6): 1076-1082.

  99. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020.

  100. Tschopp J, L’Huillier AG, Mombelli M, Mueller NJ, Khanna N, Garzoni C et al. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study. Am J Transplant. 2020.

  101. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri M. Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients. Eur Urol. 2020.

  102. Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V et al. Covid-19 and Kidney Transplantation. N Engl J Med. 2020.

  103. Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020.

  104. Columbia University Kidney Transplant Program. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. J Am Soc Nephrol. 2020; 31 (6): 1150-1156.

  105. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020.

  106. Machado DJB, Ianhez LE. COVID-19 pneumonia in kidney transplant recipients-Where we are? Transpl Infect Dis. 2020; e13306.

  107. Centro Nacional de Trasplantes (CENATRA). Boletín Informativo Especial Trasplantes y COVID-19. Información actualizada de los receptores de trasplantes y su condición respecto de la infección por SARS-CoV-2 [Internet]. 2020 [citado 27 de mayo de 2020]. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/553970/Bolet_n_Informativo_Especial_25-05-20.pdf




2020     |     www.medigraphic.com

    Este sitio utiliza cookies   Estoy de acuerdo